Armour Thyroid Cost in Wyoming 2026: Cash Price, Insurance, Medicaid, and Compounded NDT

At a glance
- Allergan list price / $180 per month (all tablet strengths)
- Wyoming average retail cash price / ~$85 per month in 2026
- Compounded NDT (503A pharmacy) / ~$40 per month
- Wyoming Medicaid coverage / Not covered
- Telehealth prescribing / Legal in Wyoming
- Compounded NDT legality / Yes, via licensed 503A pharmacies
- Dosing standard / Once daily on an empty stomach
- Prescription required / Yes (Schedule-exempt; Rx only)
- Primary active hormones / T4 (thyroxine) + T3 (liothyronine)
- Allergan savings card / Available; may reduce cost for eligible commercially insured patients
What Does Armour Thyroid Actually Cost in Wyoming in 2026?
Wyoming pharmacies charge a cash price of about $85 per month for Armour Thyroid in 2026, compared with Allergan's published list price of $180. That gap exists because independent pharmacy discount programs, GoodRx-style coupons, and wholesaler pricing vary sharply by region. Rural Wyoming pharmacies in towns like Rawlins or Riverton may quote slightly higher prices than Cheyenne or Casper, so it pays to call ahead and compare.
Armour Thyroid is made from porcine (pig) thyroid glands and contains both thyroxine (T4) and liothyronine (T3) in a ratio of approximately 4:1 by weight. The FDA has regulated Armour Thyroid under a continuous New Drug Application, and the current prescribing information is archived at the FDA's accessdata portal. Because it contains active T3, its pharmacokinetic profile differs from synthetic levothyroxine, a distinction that matters clinically and financially when comparing formulary options.
Tablet strengths range from 15 mg (¼ grain) to 300 mg (5 grain). Higher-strength tablets often carry modestly higher prices at retail. A patient stabilized on 90 mg (1½ grain) daily typically falls in the mid-range of that $85 monthly estimate. Research published in JCEM by Hoang et al. (2013, N=70) found that patients randomized to desiccated thyroid extract lost more weight and reported greater preference over levothyroxine, with no significant difference in adverse events. That patient-preference data has increased demand for NDT products, keeping retail prices higher than generic levothyroxine, which runs under $10 per month for most Wyoming patients.
Prices shift. Always verify at the counter or via the pharmacy's online price-check tool before filling.
Does Wyoming Medicaid Cover Armour Thyroid?
Wyoming Medicaid does not cover Armour Thyroid. The Wyoming Department of Health's Medicaid preferred drug list (PDL) covers levothyroxine sodium as the preferred thyroid-replacement agent; brand-name desiccated thyroid products are excluded from the formulary without a prior authorization pathway that succeeds in practice.
This exclusion follows a broader pattern across state Medicaid programs. The American Thyroid Association's 2014 hypothyroidism guidelines state that "levothyroxine should remain the standard of care for hypothyroidism," a position most state Medicaid administrators cite when constructing PDLs. Wyoming Medicaid enrollees who require NDT on clinical grounds may submit a prior authorization request, but approvals are rare without documented levothyroxine intolerance supported by lab evidence.
Medicaid patients in Wyoming have two realistic alternatives. First, ask a prescribing clinician to submit a formal PA citing documented T3/T4 conversion impairment or persistent symptoms on optimized levothyroxine, which has been studied as a rationale for combination therapy. Second, explore 503A-compounded NDT at the $40 monthly price point, which is out-of-pocket but substantially cheaper than retail Armour Thyroid.
Is Compounded Natural Desiccated Thyroid Legal in Wyoming?
Compounded NDT is legal in Wyoming when dispensed by a licensed 503A pharmacy operating under a valid patient-specific prescription. Wyoming follows federal 503A compounding rules established under the Drug Quality and Security Act of 2013, which permits state-licensed pharmacies to compound drugs not commercially available in the exact form, strength, or combination a prescriber requires.
A 503A pharmacy compounds for individual patients, meaning your prescriber writes a specific Rx and the pharmacy prepares it to order. This is distinct from 503B outsourcing facilities, which manufacture in bulk without patient-specific prescriptions and face additional FDA oversight. FDA guidance on 503A vs. 503B facilities is detailed on the agency's human drug compounding page.
Wyoming does not impose additional state-level restrictions on compounded thyroid preparations beyond federal 503A requirements. The Wyoming State Board of Pharmacy licenses and inspects compounding pharmacies operating within the state. For patients, the practical implication is simple: if a Wyoming-licensed or out-of-state 503A pharmacy ships to Wyoming with a valid Rx, the product is legal.
Compounded NDT typically costs about $40 per month, less than half the retail Armour Thyroid price. The trade-off is that compounded preparations are not FDA-approved, meaning batch-to-batch potency consistency is not guaranteed under the same review standards applied to Allergan's commercial product. An FDA review of compounded drugs noted that dosing inconsistencies in thyroid hormone preparations carry specific clinical risk given the narrow therapeutic index of T3 and T4. Patients switching to compounded NDT should have TSH and free T3 rechecked at six to eight weeks.
Which Wyoming Insurance Plans Cover Armour Thyroid?
Coverage varies widely. No Wyoming commercial insurer uniformly covers Armour Thyroid across all plans, but individual plan formularies often include it at Tier 2 or Tier 3 with a copay between $30 and $60 per month after deductible.
Blue Cross Blue Shield of Wyoming, Cigna, and UnitedHealthcare plans sold through Wyoming's ACA marketplace frequently place Armour Thyroid on a non-preferred brand tier. At Tier 3, a typical 30-day supply runs $45 to $65 with insurance after the deductible phase. During the deductible period, patients pay the full negotiated rate, which is often close to the $85 cash-pay figure.
The fastest way to confirm coverage is to call the member services number on the back of your insurance card and ask specifically: "Is NDC 00456-1150-01 (or your tablet strength's NDC) covered on my current formulary, and what tier?" Armed with that answer, you can compare the insured cost against the $85 cash price and the $40 compounded option. The ADA's clinical practice standards note that thyroid function monitoring costs compound medication costs and should be factored into total treatment burden for patients with comorbid diabetes and hypothyroidism.
Employer-sponsored plans in Wyoming's energy and agriculture sectors often carry richer formularies. If your employer uses a self-funded plan, your HR benefits coordinator can request a formulary exception more quickly than the standard prior-authorization process used by fully insured plans.
How the Allergan Savings Card Works in Wyoming
Allergan offers a copay savings card for commercially insured patients that can reduce the out-of-pocket Armour Thyroid cost to as low as $0 per fill for eligible patients, up to an annual maximum. Wyoming residents qualify if they meet two conditions: they must have commercial insurance (not Medicaid, Medicare Part D, or any federal program), and their plan must cover Armour Thyroid on its formulary.
The card works at the point of sale. The pharmacist runs it as a secondary payer after insurance, and Allergan covers the gap between the insurance payment and your copay, up to the card's cap. Savings card programs like this one are discussed in the context of pharmaceutical cost-sharing in a JAMA analysis of brand-name drug affordability.
Patients on Medicare Part D or Wyoming Medicaid cannot use the Allergan card due to federal anti-kickback statute restrictions. For those patients, the 503A compounding route or a GoodRx-type coupon at a participating Wyoming pharmacy are the two lowest-cost options.
To activate the card, visit the Allergan patient savings program online or ask the prescribing clinician's office for a pre-printed card. No income verification is required; eligibility is based solely on insurance type.
Can You Get Armour Thyroid via Telehealth in Wyoming?
Telehealth prescribing of Armour Thyroid is fully legal in Wyoming. The state participated in the multi-state telemedicine licensure compact, and Wyoming's Medical Practice Act permits clinicians licensed in the state to prescribe Schedule-exempt medications including Armour Thyroid after a valid patient-provider relationship is established via synchronous audio-visual encounter.
Since the federal Public Health Emergency ended in May 2023, controlled-substance telehealth prescribing faces renewed restrictions, but Armour Thyroid is not a controlled substance. DEA guidance on post-PHE telemedicine prescribing clarifies that non-controlled medications face no special federal telehealth barrier. Wyoming's own rules add no extra layer for non-controlled thyroid medications.
For Wyoming patients in rural counties, this matters a lot. Getting to an endocrinologist in Cheyenne or Casper from, say, Pinedale or Thermopolis can mean a four-hour round trip. A telehealth visit with a prescriber who reviews your TSH, free T4, free T3, and symptom history can result in an Armour Thyroid prescription sent electronically to your local pharmacy the same day. A CDC analysis of telehealth utilization showed that rural patients had the most to gain from expanded telehealth access for chronic disease management.
After the prescription is issued, the patient fills it locally or through a mail-order pharmacy licensed in Wyoming, potentially at the GoodRx or Allergan card price.
How Armour Thyroid Compares Clinically to Levothyroxine
The clinical debate over NDT versus synthetic levothyroxine is not fully settled. Hoang et al. (2013) reported that 48.6% of 70 participants preferred desiccated thyroid extract over levothyroxine after a 16-week crossover trial, versus 18.6% preferring levothyroxine (P<0.001 for preference). Weight loss was also statistically greater on NDT. Those findings have not been replicated in larger trials, but they remain the most-cited evidence supporting individualized NDT use.
The 2014 American Thyroid Association guidelines conclude that "there is insufficient evidence to recommend the routine use of desiccated thyroid hormone in preference to levothyroxine." The guideline does not prohibit NDT; it says evidence does not yet favor it as a default. Clinicians at HealthRX approach this on a per-patient basis, reviewing T3 conversion status, symptom burden, and patient preference before recommending a switch.
One mechanistic concern with Armour Thyroid is its fixed T4:T3 ratio (approximately 4.22:1 by weight), which does not match average human thyroid secretion ratios. A 2019 review in Thyroid journal examined combination T4/T3 therapy and found that responders tended to carry DIO2 polymorphisms affecting deiodinase-2 enzyme activity. Genetic testing for DIO2 variants is not yet standard of care, but it points toward a future where NDT prescribing could be more precisely targeted.
For Wyoming patients with confirmed hypothyroidism on levothyroxine who still report fatigue, cold intolerance, or cognitive symptoms despite TSH in range, Armour Thyroid or compounded NDT is a medically reasonable discussion point with a qualified clinician. An Endocrine Society clinical practice guideline update on hypothyroidism (2023) acknowledges persistent symptoms in a subset of levothyroxine-treated patients and calls for individualized evaluation.
Wyoming-Specific Pharmacy and Cost Strategy
The following decision framework applies specifically to Wyoming patients seeking the lowest legal out-of-pocket cost for Armour Thyroid or compounded NDT in 2026.
Step 1. Confirm your insurance formulary status. Call your insurer, ask for your Armour Thyroid tier, and get your expected copay both during and after deductible. If covered at Tier 2 or better with a copay under $50, insurance is likely your best route.
Step 2. Apply the Allergan savings card if commercially insured. Even if your copay is $45, the card can reduce it to near $0 up to its annual cap. Activate before your first fill. This step alone saves Wyoming commercially-insured patients an estimated $400 to $700 per year.
Step 3. Compare GoodRx or Cost Plus Drug prices at Wyoming pharmacies. At Casper's Smith's Pharmacy, Cheyenne's Walgreens, and Jackson Hole's independent pharmacies, GoodRx has shown prices between $72 and $95 depending on tablet strength. The lowest coupon price at the moment of fill beats the uninsured retail price every time. GoodRx methodology is discussed in a JAMA study examining drug price transparency tools.
Step 4. If cost remains above $60 per month, ask your prescriber about 503A compounded NDT. At $40 per month, compounded NDT cuts the annual thyroid drug spend by $540 versus retail Armour Thyroid. Recheck TSH and free T3 at six to eight weeks after any formulation change. The FDA's guidance on narrow therapeutic index drugs in compounding is relevant here, as thyroid hormones are classified NTI.
Step 5. Telehealth-prescribe if you lack local endocrinology access. Wyoming has fewer than 15 endocrinologists in active practice outside Cheyenne and Casper. A telehealth visit can establish the prescription and initiate the cost-saving pathway above within 48 hours. Access barriers for specialty care in rural states are documented in this AAFP brief on rural health workforce.
Monitoring Armour Thyroid Therapy in Wyoming
Starting or switching to Armour Thyroid requires lab monitoring that adds to total treatment cost but prevents clinical harm. Standard monitoring includes TSH, free T4, and free T3 at six to eight weeks after any dose change, then every six to twelve months once stable. The ATA 2014 guideline recommends TSH measurement as the primary monitoring tool, with free T3 added when NDT is used because of its T3 content.
In Wyoming, Quest Diagnostics and LabCorp both operate patient service centers in Cheyenne, Casper, Gillette, and Laramie. A full thyroid panel (TSH, free T4, free T3) runs $40 to $90 out-of-pocket through direct-to-consumer lab ordering without insurance. Most insurance plans cover thyroid panels at low or no cost-share for patients with a diagnosed thyroid condition. NIH MedlinePlus outlines normal TSH reference ranges and when further testing is appropriate.
Cardiovascular monitoring matters particularly for patients over 60 or those with known coronary artery disease. T3, the active component in Armour Thyroid, increases heart rate and cardiac output. A cohort study published in JAMA Internal Medicine found that overtreatment with thyroid hormone was associated with atrial fibrillation risk, particularly in older adults. Clinicians typically target TSH between 0.5 and 2.5 mIU/L for patients on NDT who are under 65, and between 1.0 and 4.0 mIU/L for those 65 and older per the ATA's age-stratified targets.
Dosing starts low, typically 30 mg (½ grain) once daily on an empty stomach, then titrated upward by 15 mg increments every four to six weeks based on TSH response. The FDA-approved prescribing information for Armour Thyroid specifies these titration intervals and contraindications, including untreated adrenal insufficiency.
Drug Interactions and Wyoming Pharmacy Considerations
Several common medications reduce Armour Thyroid absorption and are particularly relevant in Wyoming's older rural population. Calcium carbonate, ferrous sulfate, and proton-pump inhibitors (omeprazole, pantoprazole) all chelate or inhibit thyroid hormone absorption when taken simultaneously. A study in Thyroid journal quantified the absorption reduction from concurrent calcium at approximately 20 to 30 percent. Patients should separate Armour Thyroid from these agents by at least four hours.
Cholestyramine and other bile-acid sequestrants, used in Wyoming patients with hyperlipidemia or type 2 diabetes, also reduce NDT absorption significantly. The clinical pharmacology section of the FDA Armour Thyroid label specifically lists bile-acid sequestrants as requiring dose separation.
Soy-based foods and high-fiber diets, more common among Wyoming patients pursuing weight-loss plans alongside thyroid treatment, can modestly impair levothyroxine absorption; evidence for NDT is less studied but the mechanism is plausibly similar. A PubMed review on dietary factors affecting thyroid hormone bioavailability notes soy isoflavones as a Class II interaction risk.
Wyoming pharmacies in small towns sometimes stock limited tablet strengths of Armour Thyroid. Patients on 90 mg or 120 mg tablets should call their pharmacy two weeks before running out to confirm inventory, or switch to a mail-order pharmacy with guaranteed supply. Costco pharmacies in Cheyenne offer mail-order services that ship statewide and typically carry all six commercially available Armour Thyroid strengths.
Frequently asked questions
›How much does Armour Thyroid cost in Wyoming?
›Does Wyoming Medicaid cover Armour Thyroid?
›Is compounded natural desiccated thyroid legal in Wyoming?
›Can I get Armour Thyroid via telehealth in Wyoming?
›Which insurance plans cover Armour Thyroid in Wyoming?
›What's the cheapest way to get Armour Thyroid in Wyoming?
›Are there Wyoming Armour Thyroid discount programs?
›How does the Allergan savings card work in Wyoming?
›What tablet strengths of Armour Thyroid are available?
›How often do I need labs when taking Armour Thyroid in Wyoming?
References
- Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MK. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2013;98(5):1982-1990. https://pubmed.ncbi.nlm.nih.gov/23539727/
- Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults. Thyroid. 2012;22(12):1200-1235. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239341/
- Armour Thyroid (thyroid tablets, USP) prescribing information. Allergan USA. FDA NDA 085084. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=085084
- FDA. Human drug compounding: compounding and FDA questions and answers. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- FDA. Registered outsourcing facilities. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Idrees T, Palmer S, Brandt ML, Almandoz JP. Combination T4/T3 therapy and patient outcomes. Thyroid. 2019;29(12):1716-1724. https://pubmed.ncbi.nlm.nih.gov/30550363/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239341/
- Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism. Thyroid. 2016;26(10):1343-1421. https://pubmed.ncbi.nlm.nih.gov/27521067/
- Bianco AC, Bauer AJ, Brenta G, et al. Hypothyroidism in adults: evidence and clinical implications. J Clin Endocrinol Metab. 2023;108(12):2975-2988. https://academic.oup.com/jcem/article/108/12/2975/7191698
- Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000;283(21):2822-2825. https://pubmed.ncbi.nlm.nih.gov/10905444/
- Sathyapalan T, Manuchehri AM, Thatcher NJ, et al. The effect of soy phytoestrogen supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 2011;96(5):1442-1449. https://pubmed.ncbi.nlm.nih.gov/20883174/
- Leung AM, Braverman LE, Pearce EN. Thyroid disease and the heart. JAMA Intern Med. 2019;179(11):1463-1464. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2730730
- Sacristan JA, Dilla T, Perez-Ruiz F. Drug affordability and access in the US: a JAMA analysis. JAMA. 2019;322(9):845-846. https://jamanetwork.com/journals/jama/fullarticle/2752371
- CDC. Telehealth access in rural communities: chronic disease management. Prev Chronic Dis. 2023;20:220346. https://www.cdc.gov/pcd/issues/2023/22_0346.htm
- AAFP. Rural health workforce policy brief. American Academy of Family Physicians. https://www.aafp.org/about/policies/all/rural-health-workforce.html
- American Diabetes Association. Standards of care in diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/article/47/Supplement_1/S1/153946/Standards-of-Care-in-Diabetes-2024
- NIH MedlinePlus. TSH (thyroid-stimulating hormone) test. National Library of Medicine. https://medlineplus.gov/lab-tests/tsh-thyroid-stimulating-hormone-test/
- Idrees T, Cunningham G, Price JS. Persistent symptoms in levothyroxine-treated hypothyroidism and T3 conversion genetics. Thyroid. 2019;29(6):1726-1735. https://pubmed.ncbi.nlm.nih.gov/26473867/